91 related articles for article (PubMed ID: 91026)
1. Effect of oral contraceptives on platelet noradrenaline and5-hydroxytryptamine receptors and aggregation.
Peters JR; Elliott JM; Grahame-Smith DG
Lancet; 1979 Nov; 2(8149):933-6. PubMed ID: 91026
[TBL] [Abstract][Full Text] [Related]
2. Changes in insulin receptors during oral contraception.
De Pirro R; Forte F; Bertoli A; Greco AV; Lauro R
J Clin Endocrinol Metab; 1981 Jan; 52(1):29-33. PubMed ID: 7451643
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin III and platelets during the normal menstrual cycle and in women receiving oral contraceptives low in oestrogen.
Jespersen J; Ingeberg S; Bach E
Gynecol Obstet Invest; 1983; 15(3):153-62. PubMed ID: 6832651
[TBL] [Abstract][Full Text] [Related]
4. Characterization of receptors mediating 5-hydroxytryptamine- and catecholamine-induced platelet aggregation, assessed by the actions of alpha- and beta-blockers, butyrophenones, 5-HT antagonists and chlorpromazine.
Boullin DJ; Glenton PA
Br J Pharmacol; 1978 Apr; 62(4):537-42. PubMed ID: 26445
[TBL] [Abstract][Full Text] [Related]
5. Blood platelet biochemistry in women receiving steroid contraceptives.
Briggs M
Haematologia (Budap); 1973; 7(3):347-67. PubMed ID: 4790074
[No Abstract] [Full Text] [Related]
6. [Clinical study and effect on the uterine receptor of the combination Norgestrel-Ethinyl-Estradiol (FH 122-A) in 500 menstrual cycles].
Lévrier M
Bord Med; 1970 Jan; 3(1):225-6. PubMed ID: 4948561
[No Abstract] [Full Text] [Related]
7. Oestrogen and progesterone change the binding characteristics of alpha-adrenergic and serotonin receptors on rabbit platelets.
Elliott JM; Peters JR; Grahame-Smith DG
Eur J Pharmacol; 1980 Aug; 66(1):21-30. PubMed ID: 6250862
[TBL] [Abstract][Full Text] [Related]
8. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
Nash AL; Cornish EJ; Hain R
Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of acetylsalicylic acid on human platelet function in normal volunteers and in women using a combined oral contraceptive regime.
Baele G; Thiery M; Vermeulen A; Barbier F
Thromb Haemost; 1976 Dec; 36(3):623-7. PubMed ID: 1037156
[TBL] [Abstract][Full Text] [Related]
10. Metabolic effects of a combination of dl-norgestrel and ethinylestradiol in humans.
Gerhards E; Lachnit U; Gaude R; Schillinger E
Arzneimittelforschung; 1973 Jun; 23(6):779-84. PubMed ID: 4740760
[No Abstract] [Full Text] [Related]
11. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
Zellner P; Klinger G
Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
[No Abstract] [Full Text] [Related]
12. Clinical use of norgestrel-ethinyl oestradiol as a contraceptive.
Tyler ET; Matsner EM; Gotlib MH; Levin M; Daniels T; Shimabukuro B; Dolman H; Elliot J
J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:109-16. PubMed ID: 5288229
[No Abstract] [Full Text] [Related]
13. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
Jespersen J; Kluft C
Scand J Clin Lab Invest; 1982 Nov; 42(7):563-6. PubMed ID: 6818678
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
Lemay A; Dewailly SD; Grenier R; Huard J
J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
[TBL] [Abstract][Full Text] [Related]
15. Agonist regulation of the human platelet alpha-adrenergic receptor.
Cooper B; Handin RI; Young LH; Alexander RW
Nature; 1978 Aug; 274(5672):703-6. PubMed ID: 209342
[No Abstract] [Full Text] [Related]
16. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
17. [Changes in laboratory tests after treatment with a new contraceptive agent].
Cervantes LF; López Barcena J; Calderón Márquez JJ
Ginecol Obstet Mex; 1978 Apr; 43(258):285-97. PubMed ID: 80349
[No Abstract] [Full Text] [Related]
18. Plasma prolactin concentrations in women treated with low dose combination type oral contraceptives and in women using a d-norgestrel-releasing intrauterine device.
Nilsson CG; Lähteenmäki P
Ann Clin Res; 1978 Aug; 10(4):242-5. PubMed ID: 707973
[TBL] [Abstract][Full Text] [Related]
19. Alpha fetoprotein levels in women taking oral contraceptives.
Seppälä M
Int J Fertil; 1973; 18(4):206-8. PubMed ID: 4359688
[No Abstract] [Full Text] [Related]
20. The influence of Na+ on the alpha 2-adrenergic receptor system of human platelets. A method for removal of extraplatelet Na+. Effect of Na+ removal on aggregation, secretion, and cAMP accumulation.
Connolly TM; Limbird LE
J Biol Chem; 1983 Mar; 258(6):3907-12. PubMed ID: 6300061
[No Abstract] [Full Text] [Related]
[Next] [New Search]
